{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T02:06:29Z","timestamp":1769565989678,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"name":"Private Universit\u00e4t Witten\/Herdecke gGmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>Kutane Metastasen eines Pleuramesothelioms sind selten und stellen aufgrund ihrer histopathologischen Heterogenit\u00e4t eine diagnostische Herausforderung dar. Wir pr\u00e4sentieren einen Fall, bei dem initial f\u00e4lschlicherweise ein kutanes Plattenepithelkarzinom diagnostiziert wurde. Die korrekte Diagnose einer kutanen Metastasierung eines vorbekannten Pleuramesothelioms konnte erst durch eine differenzierte immunhistochemische Analyse gesichert werden. Die pr\u00e4zise histologische Klassifikation ist von hoher klinischer Relevanz, da das therapeutische Vorgehen insbesondere vom histologischen Subtyp sowie dem ECOG-Performance-Status des Patienten abh\u00e4ngt. Eine fr\u00fchzeitige und exakte Diagnosestellung sowie die darauf basierende ad\u00e4quate Therapieeinleitung sind prognostisch von entscheidender Bedeutung.<\/jats:p>","DOI":"10.1007\/s00105-025-05575-0","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:42:24Z","timestamp":1759938144000},"page":"131-135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Kutane Fernmetastase eines Pleuramesothelioms","Cutaneous metastasis of pleural mesothelioma"],"prefix":"10.1007","volume":"77","author":[{"given":"Antigona","family":"Aliu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Hohaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich Peter","family":"Wehry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zain","family":"Deeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Oellig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thilo","family":"Gambichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven-Niklas","family":"Burmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kreuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"5575_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jdcr.2024.08.033","volume":"54","author":"W Abou Shahla","year":"2024","unstructured":"Abou Shahla\u00a0W, Khoury\u00a0DM, Saade\u00a0D (2024) Cutaneous metastasis from pleural mesothelioma at site of radiation therapy: Case report and review of the literature. JAAD Case Rep 54:37\u201340","journal-title":"JAAD Case Rep"},{"key":"5575_CR2","unstructured":"Metzenmacher M, Aigner C, Curioni-Fontecedro A et\u00a0al (2023) Malignes Pleuramesotheliom (ICD-10: C45.0) \u2013 Leitlinie zur Diagnostik und Therapie h\u00e4matologischer und onkologischer Erkrankungen. Deutsche Gesellschaft f\u00fcr H\u00e4matologie und Medizinische Onkologie (DGHO). https:\/\/www.onkopedia.com\/de\/onkopedia\/guidelines\/pleuramesotheliom\/@@guideline\/html\/index.html#litID0E3KAG. Zugegriffen: 2015"},{"issue":"2","key":"5575_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","volume":"11","author":"F Galateau-Salle","year":"2016","unstructured":"Galateau-Salle\u00a0F, Churg\u00a0A, Roggli\u00a0V et\u00a0al (2016) World Health Organization Committee for Tumors of the Pleura. The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification. J\u00a0Thorac Oncol 11(2):142\u2013154","journal-title":"J Thorac Oncol"},{"key":"5575_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00428-021-03031-7","volume":"478","author":"MB Beasley","year":"2021","unstructured":"Beasley\u00a0MB, Galateau-Salle\u00a0F, Dacic\u00a0S (2021) Pleural mesothelioma classification update. Virchows Arch 478:59\u201372","journal-title":"Virchows Arch"},{"issue":"Suppl\u00a01","key":"5575_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41379-021-00895-7","volume":"35","author":"S Dacic","year":"2022","unstructured":"Dacic\u00a0S (2022) Pleural mesothelioma classification\u2014update and challenges. Mod Pathol 35(Suppl\u00a01):51\u201356","journal-title":"Mod Pathol"},{"issue":"12","key":"5575_CR6","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/cup.13026","volume":"44","author":"RE Ward","year":"2017","unstructured":"Ward\u00a0RE, Ali\u00a0SA, Kuhar\u00a0M (2017) Epithelioid malignant mesothelioma metastatic to the skin: a\u00a0case report and review of the literature. J\u00a0Cutan Pathol 44(12):1057\u20131063","journal-title":"J Cutan Pathol"},{"issue":"5","key":"5575_CR7","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.abd.2020.07.020","volume":"96","author":"T Mori","year":"2021","unstructured":"Mori\u00a0T, Yamamoto\u00a0T (2021) Skin metastasis of malignant mesothelioma. An Bras Dermatol 96(5):642\u2013643","journal-title":"An Bras Dermatol"},{"key":"5575_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1477-7819-7-84","volume":"7","author":"AM Elbahaie","year":"2009","unstructured":"Elbahaie\u00a0AM, Kamel\u00a0DE, Lawrence\u00a0J et\u00a0al (2009) Late cutaneous metastases to the face from malignant pleural mesothelioma: a\u00a0case report and review of the literature. World J Surg Oncol 7:84","journal-title":"World J Surg Oncol"},{"issue":"7","key":"5575_CR9","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/cup.13927","volume":"48","author":"K Collins","year":"2020","unstructured":"Collins\u00a0K, Nagarajan\u00a0P, Aung\u00a0PP (2020) Distant cutaneous metastasis of malignant epithelioid mesothelioma. J\u00a0Cutan Pathol 48(7):902\u2013907","journal-title":"J Cutan Pathol"},{"issue":"3","key":"5575_CR10","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4103\/0019-5154.131420","volume":"59","author":"E Ruocco","year":"2014","unstructured":"Ruocco\u00a0E, Caccavale\u00a0S, Siano\u00a0M et\u00a0al (2014) Radiation port cutaneous metastases: a\u00a0further example of immunocompromised district. Indian J Dermatol 59(3):302\u2013303","journal-title":"Indian J Dermatol"},{"issue":"6","key":"5575_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1600-0560.2008.01094.x","volume":"36","author":"C Abban","year":"2009","unstructured":"Abban\u00a0C, Viglione\u00a0M (2009) Peritoneal mesothelioma presenting as a\u00a0skin nodule. J\u00a0Cutan 36(6):675\u2013679","journal-title":"J Cutan"},{"issue":"1","key":"5575_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/PAI.0b013e3181e94121","volume":"19","author":"T Terada","year":"2011","unstructured":"Terada\u00a0T (2011) Skin metastasis of pleural epithelioid malignant mesothelioma. Appl Immunohistochem Mol Morphol 19(1):92\u201393","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"5575_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/CCO.0000000000000697","volume":"33","author":"K Sinn","year":"2021","unstructured":"Sinn\u00a0K, Mosleh\u00a0B, Hoda\u00a0MA (2021) Malignant pleural mesothelioma: recent developments. Curr Opin Oncol 33(1):80\u201386","journal-title":"Curr Opin Oncol"},{"key":"5575_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","volume":"397","author":"P Baas","year":"2021","unstructured":"Baas\u00a0P, Scherpereel\u00a0A, Nowak\u00a0AK et\u00a0al (2021) First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a\u00a0multicentre, randomised, open-label, phase\u00a03\u00a0trial. Lancet 397:375\u2013386","journal-title":"Lancet"},{"key":"5575_CR15","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang\u00a0NJ, Rusthoven\u00a0JJ, Symanowski\u00a0J et\u00a0al (2003) Phase\u00a0III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J\u00a0Clin Oncol 21:2636\u20132644","journal-title":"J Clin Oncol"},{"issue":"12","key":"5575_CR16","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1016\/S1470-2045(19)30532-7","volume":"20","author":"GL Ceresoli","year":"2019","unstructured":"Ceresoli\u00a0GL, Aerts\u00a0JG, Dziadziuszko\u00a0R et\u00a0al (2019) Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a\u00a0multicentre, single-arm phase\u00a02\u00a0trial. Lancet Oncol 20(12):1702\u20131709","journal-title":"Lancet Oncol"},{"issue":"6","key":"5575_CR17","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S2213-2600(20)30362-3","volume":"9","author":"CJ de Gooijer","year":"2021","unstructured":"de Gooijer\u00a0CJ, van der Noort\u00a0V, Stigt\u00a0JA et\u00a0al (2021) Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase\u00a02\u00a0trial. Lancet Respir Med 9(6):585\u2013592","journal-title":"Lancet Respir Med"},{"issue":"3","key":"5575_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.lungcan.2014.03.006","volume":"84","author":"MG Zauderer","year":"2014","unstructured":"Zauderer\u00a0MG, Kass\u00a0SL, Woo\u00a0K et\u00a0al (2014) Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma. Lung Cancer 84(3):271\u2013274","journal-title":"Lung Cancer"},{"issue":"4","key":"5575_CR19","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s13193-023-01811-y","volume":"14","author":"MA Osama","year":"2023","unstructured":"Osama\u00a0MA, Gaur\u00a0K, Chatterjee\u00a0P et\u00a0al (2023) Acantholytic Squamous Cell Carcinoma: a\u00a0Diagnostic Pitfall on Cytology. Indian J Surg Oncol 14(4):963\u2013967","journal-title":"Indian J Surg Oncol"},{"issue":"Suppl\u00a01","key":"5575_CR20","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.4103\/0973-029X.141359","volume":"18","author":"K Mardi","year":"2014","unstructured":"Mardi\u00a0K, Singh\u00a0N (2014) Acantholytic squamous cell carcinoma of the oral cavity: A\u00a0rare entity. J\u00a0Oral Maxillofac Pathol 18(Suppl\u00a01):S128\u201330","journal-title":"J Oral Maxillofac Pathol"},{"key":"5575_CR21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12885-018-4218-8","volume":"18","author":"K Yorita","year":"2018","unstructured":"Yorita\u00a0K, Tsuji\u00a0K, Takano\u00a0Y et\u00a0al (2018) Acantholytic squamous cell carcinoma of the lung with marked lymphogenous metastases and high titers of myeloperoxidase-antineutrophil cytoplasmic antibodies: a\u00a0case report. Bmc Cancer 18:300","journal-title":"Bmc Cancer"},{"issue":"3","key":"5575_CR22","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1046\/j.1365-2559.2000.00999.x","volume":"37","author":"TW Beer","year":"2000","unstructured":"Beer\u00a0TW, Shepherd\u00a0P, Theaker\u00a0JM (2000) Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin. Histopathology 37(3):218\u2013223","journal-title":"Histopathology"},{"issue":"1","key":"5575_CR23","first-page":"59","volume":"29","author":"AM Pisacane","year":"2007","unstructured":"Pisacane\u00a0AM, Picciotto\u00a0F, Risio\u00a0M (2007) CD31 and CD34 expression as immunohistochemical markers of endothelial transdifferentiation in human cutaneous melanoma. Cell Oncol 29(1):59\u201366","journal-title":"Cell Oncol"},{"key":"5575_CR24","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1158\/1078-0432.CCR-04-2236","volume":"11","author":"JL Dennis","year":"2005","unstructured":"Dennis\u00a0JL, Hvidsten\u00a0TR, Wit\u00a0EC et\u00a0al (2005) Markers of adenocarcinoma characteristic of the site of origin: development of a\u00a0diagnostic algorithm. Clin Cancer Res 11:3766\u20133772","journal-title":"Clin Cancer Res"},{"issue":"3","key":"5575_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/modpathol.2011.173","volume":"25","author":"JA Bishop","year":"2012","unstructured":"Bishop\u00a0JA, Teruya-Feldstein\u00a0J, Westra\u00a0WH et\u00a0al (2012) p40 (\u2206Np63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod Pathol 25(3):405\u2013415","journal-title":"Mod Pathol"},{"issue":"4","key":"5575_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.humpath.2005.01.019","volume":"36","author":"NG Ord\u00f3\u00f1ez","year":"2005","unstructured":"Ord\u00f3\u00f1ez\u00a0NG (2005) D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum Pathol 36(4):372\u2013380","journal-title":"Hum Pathol"},{"issue":"4","key":"5575_CR27","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1365-2559.2005.02098.x","volume":"46","author":"M Fukunaga","year":"2005","unstructured":"Fukunaga\u00a0M (2005) Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology 46(4):396\u2013402","journal-title":"Histopathology"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-025-05575-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-025-05575-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-025-05575-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:19:04Z","timestamp":1769519944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-025-05575-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["5575"],"URL":"https:\/\/doi.org\/10.1007\/s00105-025-05575-0","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"7 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Aliu, K.\u00a0Hohaus, U.P.\u00a0Wehry, Z.\u00a0Deeb, F.\u00a0Oellig, T.\u00a0Gambichler, S.-N.\u00a0Burmann und A.\u00a0Kreuter geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}